Healthcare staffing company AMN Healthcare Services (NYSE: AMN) announced better-than-expected revenue in Q2 CY2026, with sales up 2.3% year on year to $673.2 million. On top of that, next quarter’s revenue guidance ($647.5 million at the midpoint) was surprisingly good and 4.7% above what analysts were expecting. Its non-GAAP profit of $0.77 per share was significantly above analysts’ consensus estimates.
Is now the time to buy AMN? Find out in our full research report (it’s free for active Edge members).
AMN Healthcare Services (AMN) Q2 CY2026 Highlights:
- Revenue: $673.2 million vs analyst estimates of $628.2 million (2.3% year-on-year growth, 7.2% beat)
- Adjusted EPS: $0.77 vs analyst estimates of $0.19 (significant beat)
- Adjusted EBITDA: $73.36 million vs analyst estimates of $43.27 million (10.9% margin, 69.5% beat)
- Revenue Guidance for Q3 CY2026 is $647.5 million at the midpoint, above analyst estimates of $618.2 million
- Operating Margin: 4%, up from -18.8% in the same quarter last year
- Sales Volumes were up 5.7% year on year
- Market Capitalization: $1.19 billion
StockStory’s Take
AMN Healthcare Services delivered second quarter results that exceeded Wall Street’s expectations, with management attributing the strong performance primarily to robust demand in its Nurse and Allied Solutions segment. CEO Caroline Grace pointed to travel nurse and allied staffing volumes growing at their highest rate in four years, reflecting both increased patient demand and AMN’s focused investments in automation and technology-driven fulfillment. The company also benefited from higher-than-expected labor disruption revenue and improved execution in its search and international nurse businesses, helping lift both revenue and margins for the quarter.
Looking ahead, AMN’s positive guidance is supported by sustained momentum in its core staffing businesses and ongoing investments in technology and process automation. Management expects volume growth in travel nurse and allied staffing to remain strong, while new enhancements to digital platforms and recent acquisitions are aimed at broadening the company’s capabilities. CFO Brian Scott noted that the company is positioned to leverage further demand acceleration and industry consolidation, stating, “We are better positioned now if the right opportunity comes along, and we can participate more actively than 12 or 24 months ago.”
Key Insights from Management’s Remarks
Management attributed the quarter’s outperformance to broad-based demand increases, technology-driven improvements in fill rates, and targeted acquisitions that enhanced AMN’s solutions portfolio.
- Nurse and Allied demand surge: Travel nurse and allied staffing volumes grew 6% and 7% year-over-year, respectively, marking the highest growth rates in four years. Management cited broad-based demand across healthcare providers and service models, with improved order fill rates supported by automation and AI-enabled recruiting.
- Labor disruption and margin lift: Higher-than-expected labor disruption revenue and several one-time reserve adjustments contributed to gross margin and EBITDA gains. CFO Brian Scott highlighted that, even excluding these items, underlying performance was at the top end of management’s expectations, with process automation and 24/7 operations cited as key enablers.
- International nurse and search momentum: International nurse revenue increased 23% year-over-year, supported by forward movement in visa application processes. The search business, encompassing both physician and executive search, saw strong double-digit growth driven by executive turnover and new facility expansions, particularly in academic medical centers.
- Technology and Workforce Solutions pressure: Revenue in the Technology and Workforce Solutions segment declined 15% year-over-year, with pricing headwinds in language services and competitive pressures in vendor management systems. Management expects ongoing challenges here but is focused on cost optimization, tiered service offerings, and recent platform enhancements.
- Strategic acquisitions and leadership additions: Two small acquisitions—Jaide Health for language services and ESSENTIAL Leadership for search—extended AMN’s capabilities. The company also welcomed a new Chief People Officer and Chief Commercial Officer to drive its talent and commercial strategies.
Drivers of Future Performance
Management expects continued growth in core staffing volumes, margin normalization, and targeted investments in technology to shape performance in upcoming quarters.
- Sustained demand in Nurse and Allied: AMN projects double-digit year-over-year volume growth in travel nurse and allied staffing, driven by persistent patient demand and broader adoption of contingent labor as hospitals seek flexibility. Management notes that improved automation and higher fill rates position the company to capture share as volumes rise.
- Margin normalization and mix effects: While Q2 margins were elevated by one-time items, future margins are expected to normalize as labor disruption revenues revert and the business mix shifts toward lower-margin segments like Technology and Workforce Solutions. Management highlighted ongoing cost controls and efficiency gains to support profitability.
- Industry consolidation and M&A optionality: AMN is positioned to benefit from accelerating consolidation in healthcare staffing, with a strengthened balance sheet enabling more active participation in M&A. Management will continue to evaluate opportunities that enhance its solutions portfolio and address evolving client needs.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be watching (1) whether double-digit growth in travel nurse and allied staffing is sustained amid fluctuating hospital demand, (2) the pace and impact of AMN’s technology platform enhancements and AI-driven recruiting on fill rates, and (3) the outcome of ongoing industry consolidation efforts, including AMN’s ability to deploy capital for strategic acquisitions. We will also monitor margin trends as the business mix evolves.
AMN Healthcare Services currently trades at $34.87, up from $30.80 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
High Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
